Page last updated: 2024-08-25

beta-hydroxyisovaleric acid and Bone Loss, Perimenopausal

beta-hydroxyisovaleric acid has been researched along with Bone Loss, Perimenopausal in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Krupski, W; Majer-Dziedzic, B; Tatara, MR	1

Other Studies

1 other study(ies) available for beta-hydroxyisovaleric acid and Bone Loss, Perimenopausal

Article	Year
Bone mineral density changes of lumbar spine and femur in osteoporotic patient treated with bisphosphonates and beta-hydroxy-beta-methylbutyrate (HMB): Case report. Medicine, 2017, Volume: 96, Issue:41 Topics: Absorptiometry, Photon; Anabolic Agents; Bone Density; Bone Density Conservation Agents; Diphosphonates; Female; Femur; Humans; Lumbar Vertebrae; Middle Aged; Osteoporosis, Postmenopausal; Severity of Illness Index; Time; Tomography, X-Ray Computed; Treatment Outcome; Valerates	2017

Article

Year

Bone mineral density changes of lumbar spine and femur in osteoporotic patient treated with bisphosphonates and beta-hydroxy-beta-methylbutyrate (HMB): Case report.

Medicine, 2017, Volume: 96, Issue:41

Topics: Absorptiometry, Photon; Anabolic Agents; Bone Density; Bone Density Conservation Agents; Diphosphonates; Female; Femur; Humans; Lumbar Vertebrae; Middle Aged; Osteoporosis, Postmenopausal; Severity of Illness Index; Time; Tomography, X-Ray Computed; Treatment Outcome; Valerates

2017